Brent Vaughan

CEO & Co-Founder, Cognoa

Brent is CEO and co-founder of Cognoa, a pediatric behavioral health company that has received FDA Breakthrough Designation for its first two prescription digital therapeutics designed to improve the standard of care for the early diagnosis and treatment of behavioral health conditions, starting with autism. Brent is a career biopharma and medtech executive, having previously co-founded WellnessFX, a digital health company that created a direct-to-consumer diagnostics and telemedicine platform, as well as holding leadership positions in business development, product management and corporate strategy at Chiron/Novartis, Nektar and Roche.